A viral kinetic study using pegylated interferon alfa-2b and/or lamivudine in patients with chronic hepatitis B/HBeAg negative-Reference-Cited by-同舟云学术

A viral kinetic study using pegylated interferon alfa-2b and/or lamivudine in patients with chronic hepatitis B/HBeAg negative

Published:2005-07 Issue:1 Volume:42 Page:77-85
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Sypsa Vassiliki-Anastasia,Mimidis Konstantinos,Tassopoulos Nicholas C.,Chrysagis Dimitrios,Vassiliadis Themistoklis,Moulakakis Antonios,Raptopoulou Maria,Haida Caterina,Hatzakis Angelos

Publisher

Wiley

Subject

Hepatology

Reference21 articles.

1. Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B;Cooksley;J Viral Hepatol,2003

2. Treatment with interferons (including pegylated interferons) in patients with hepatitis B;Cooksley;Semin Liver Dis,2004

3. Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B;Marcellin;N Engl J Med,2004

4. Viral dynamics during PEG-interferon alone and in combination with lamivudine;van Zonneveld;J Hepatol,2004

5. HIV-1 Dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time;Perelson;Science,1996

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An optimized mode of interferon intermittent therapy help improve HBsAg disappearance in chronic hepatitis B patients;Frontiers in Microbiology;2022-08-30

2. Analysis of a diffusive HBV model with logistic proliferation and non-cytopathic antiviral mechanisms;Communications in Nonlinear Science and Numerical Simulation;2022-03

3. What drives the dynamics of HBV RNA during treatment?;Journal of Viral Hepatitis;2020-11-02

4. In Vivo Delivery of Cassettes Encoding Anti-HBV Primary MicroRNAs Using an Ancestral Adeno-Associated Viral Vector;RNA Interference and CRISPR Technologies;2020

5. Within-host mathematical models of hepatitis B virus infection: Past, present, and future;Current Opinion in Systems Biology;2019-12